molecule.to
Get leads like Molecule — and thousands more
Build targeted lists by tech stack, traffic, and more
Molecule Protocol: Biopharma's DeFi Experiment
A 41-person team is tokenizing drug IP and it's actually working.
Imagine buying a fraction of a cancer drug's future royalties, traded like crypto. Molecule Protocol is making that reality, turning biopharma intellectual property into tradable IP-NFTs and connecting scientists with capital markets.
"They're not building a biotech company—they're building the financial rails for the entire industry's intellectual property."
The Growth Story
Molecule's traffic profile reveals a niche but engaged audience. With 5,096 monthly visits, they're not chasing mass-market appeal. The 48% direct traffic suggests a core community of crypto-native biotech enthusiasts who know exactly where to find them. This isn't accidental growth—it's product-market fit in a hyper-specific intersection: decentralized science (DeSci) meets biopharma.
The User Base
Their audience is a rare hybrid: PhD-level scientists, crypto investors, and pharmaceutical insiders. The search data proves it—queries like 'molecule ipnfts' and 'molecule.xyz berlin' show a global, technical user base. They're not optimizing for Google—they're building for a community that speaks both molecular biology and Solidity.
The financials are telling. $6.4M in revenue with just 41 employees means ~$156K revenue per employee—exceptional for a biotech platform. Yet they list funding as 'N/A,' suggesting they're either bootstrapped or revenue-funded. This isn't a VC-burn machine; it's a capital-efficient operation that likely takes a cut of IP-NFT transactions or licensing deals.
- IP-NFTs: Tokenizing drug patents as intellectual property non-fungible tokens
- Molecule Catalyst: A funding platform connecting researchers with capital
- DeSci DAO: Community governance over scientific funding decisions
- IP Licensing: On-chain IP licensing and revenue-sharing agreements
The Verdict: High-Risk, High-Reward Infrastructure Play
Molecule Protocol is betting that DeFi can fix biopharma's funding crisis. With $6.4M revenue and a lean team, they're proving the model works—but the real test is scaling beyond early adopters.
What tech stack does Molecule use?
How much traffic does Molecule get?
Traffic & Engagement
Traffic Sources
Where is Molecule's audience located?
What keywords does Molecule rank for?
5 keywordsHow is Molecule's SEO?
Open Graph Image
https://cdn.prod.website-files.com/5fcf058ca5a742c36f247ef0/623dc1aa776dfa295e12322c_Molecule-Opengraph-Image.jpg
Meta Tags
Molecule Protocol Home | A New Era of Drug Development
Funding and tokenization platform for biopharma intellectual property.
H1 Tags
What is Molecule's revenue?
Who works at Molecule?
Loading leads...
What do customers think of Molecule?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Molecule
What is Molecule's Revenue?
What does Molecule do?
How fast is Molecule growing?
What technologies does Molecule use?
Who are Molecule's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Molecule?
Contact Information
Export molecule.to Data
Download the complete tech stack, analytics, leads, and company data for molecule.to in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About molecule.to
Funding and tokenization platform for biopharma intellectual property.
Company Overview
molecule.to Social Media
Contact molecule.to
Email Addresses
Phone Numbers
Technology Stack
molecule.to uses 17 technologies across their website including Font Awesome, HSTS, Webflow, and more.
Fonts
Font Awesome
Security
HSTS
CMS
Webflow
CDN
unpkg, jsDelivr
Cloud & Hosting
AWS CloudFront
Advertising
Twitter Pixel
Traffic & Audience
molecule.to receives approximately 5.1K monthly visitors and ranks #3,619,637 globally. The website has a bounce rate of 36% with visitors viewing an average of 1.8 pages per visit. Users spend an average of 0:18 on the site.
The majority of molecule.to's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is molecule.to?
What technologies does molecule.to use?
How do I contact molecule.to?
What are molecule.to's social media accounts?
Is molecule.to hiring?
How popular is molecule.to?
Related Searches
This page provides publicly available information about molecule.to. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit molecule.to directly at https://molecule.to.